Literature DB >> 22177347

Olfactory processing, sex effects and heterogeneity in schizophrenia.

Dolores Malaspina1, Raymond Goetz, Andreas Keller, Julie W Messinger, Gerard Bruder, Deborah Goetz, Mark Opler, Susan Harlap, Jill Harkavy-Friedman, Daniel Antonius.   

Abstract

INTRODUCTION: Smell identification deficits are associated with negative symptoms in schizophrenia, particularly in males. Far less information is known about the relationship of odor detection sensitivity (acuity) and negative symptoms in schizophrenia, and currently there is a dearth in sex-stratified research specifically examining odor sensitivity and smell identification.
METHODS: Fifty-eight individuals with schizophrenia and 42 healthy comparison subjects were assessed on tests of odor sensitivity, smell identification and cognition. Negative symptoms were assessed with the Positive and Negative Syndrome Scale and the Schedule for the Deficit Syndrome.
RESULTS: In healthy males, increased odor detection sensitivity predicted better smell identification scores. In contrast, male schizophrenia patients showed a significant inverse relationship, in which increased odor sensitivity predicted lower smell identification scores. Odor sensitivity and smell identification were unrelated in both schizophrenia and healthy females. Olfactory processing was strongly linked to negative symptoms, but the relationships differed by sex. Emotional expression deficits were related to odor detection hypersensitivity in female patients, whereas smell identification deficits predicted these emotional deficits in male cases.
CONCLUSION: Sex differences in olfactory functioning were identified in healthy subjects and in schizophrenia patients. Smell identification was related to negative symptoms in males with schizophrenia, whereas odor detection sensitivity predicted these features in females. Sex differences should be considered in future analyses that employ odor stimuli for neuropsychiatric research.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22177347      PMCID: PMC3288877          DOI: 10.1016/j.schres.2011.11.025

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  43 in total

Review 1.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

Review 2.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

3.  Sex differences in olfactory function in schizophrenia.

Authors:  L Kopala; C Clark; T A Hurwitz
Journal:  Am J Psychiatry       Date:  1989-10       Impact factor: 18.112

4.  Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures.

Authors:  Paul J Moberg; Steven E Arnold; Richard L Doty; Raquel E Gur; Catherine C Balderston; David R Roalf; Ruben C Gur; Christian G Kohler; Stephen J Kanes; Steven J Siegel; Bruce I Turetsky
Journal:  J Clin Exp Neuropsychol       Date:  2006-11       Impact factor: 2.475

5.  Olfactory identification and psychosis.

Authors:  K M Striebel; B Beyerstein; R A Remick; L Kopala; W G Honer
Journal:  Biol Psychiatry       Date:  1999-06-01       Impact factor: 13.382

6.  Olfactory deficits in neuroleptic naive patients with schizophrenia.

Authors:  L C Kopala; C Clark; T Hurwitz
Journal:  Schizophr Res       Date:  1993-01       Impact factor: 4.939

7.  Chemosensory event-related potentials in relation to side of stimulation, age, sex, and stimulus concentration.

Authors:  B A Stuck; S Frey; C Freiburg; K Hörmann; T Zahnert; T Hummel
Journal:  Clin Neurophysiol       Date:  2006-05-02       Impact factor: 3.708

8.  Why sex matters: brain size independent differences in gray matter distributions between men and women.

Authors:  Eileen Luders; Christian Gaser; Katherine L Narr; Arthur W Toga
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

9.  Odor identification impairments in schizophrenia: relationship with demographic measures, clinical variables, and diagnostic subtypes.

Authors:  Eliza Coleman; Raymond R Goetz; David Leitman; Scott Yale; Ariel Stanford; Jack M Gorman; Dolores Malaspina
Journal:  CNS Spectr       Date:  2002-01       Impact factor: 3.790

10.  Sex differences in temporo-limbic and frontal brain volumes of healthy adults.

Authors:  Ruben C Gur; Faith Gunning-Dixon; Warren B Bilker; Raquel E Gur
Journal:  Cereb Cortex       Date:  2002-09       Impact factor: 5.357

View more
  15 in total

1.  Smell identification in individuals at clinical high risk for schizophrenia.

Authors:  Kelly Elizabeth Gill; Elizabeth Evans; Jürgen Kayser; Shelly Ben-David; Julie Messinger; Gerard Bruder; Dolores Malaspina; Cheryl Mary Corcoran
Journal:  Psychiatry Res       Date:  2014-07-17       Impact factor: 3.222

2.  Oxytocin administration selectively improves olfactory detection thresholds for lyral in patients with schizophrenia.

Authors:  J D Woolley; O Lam; B Chuang; J M Ford; D H Mathalon; S Vinogradov
Journal:  Psychoneuroendocrinology       Date:  2015-01-07       Impact factor: 4.905

3.  Olfactory performance segregates effects of anhedonia and anxiety on social function in patients with schizophrenia.

Authors:  Kristina Cieslak; Julie Walsh-Messinger; Arielle Stanford; Leila Vaez-Azizi; Daniel Antonius; Jill Harkavy-Friedman; Deborah Goetz; Raymond R Goetz; Dolores Malaspina
Journal:  J Psychiatry Neurosci       Date:  2015-11       Impact factor: 6.186

4.  Brief Report: Olfactory Adaptation in Children with Autism Spectrum Disorders.

Authors:  Hirokazu Kumazaki; Taro Muramatsu; Masutomo Miyao; Ken-Ichi Okada; Masaru Mimura; Mitsuru Kikuchi
Journal:  J Autism Dev Disord       Date:  2019-08

5.  Sex differences in hedonic judgement of odors in schizophrenia cases and healthy controls.

Authors:  Julie Walsh-Messinger; Philip S Wong; Daniel Antonius; Kevin McMahon; Lewis A Opler; Paul Michael Ramirez; Dolores Malaspina
Journal:  Psychiatry Res       Date:  2018-08-20       Impact factor: 3.222

6.  Olfactory acuity is associated with mood and function in a pilot study of stable bipolar disorder patients.

Authors:  Caitlin Hardy; Mary Rosedale; Julie W Messinger; Karine Kleinhaus; Nicole Aujero; Hanna Silva; Raymond R Goetz; Deborah Goetz; Jill Harkavy-Friedman; Dolores Malaspina
Journal:  Bipolar Disord       Date:  2012-02       Impact factor: 6.744

7.  Normal sexual dimorphism in theory of mind circuitry is reversed in Schizophrenia.

Authors:  Julie Walsh-Messinger; Christine Stepanek; Julia Wiedemann; Deborah Goetz; Raymond R Goetz; Dolores Malaspina
Journal:  Soc Neurosci       Date:  2018-10-29       Impact factor: 2.083

Review 8.  Translational potential of olfactory mucosa for the study of neuropsychiatric illness.

Authors:  K Borgmann-Winter; S L Willard; D Sinclair; N Mirza; B Turetsky; S Berretta; C-G Hahn
Journal:  Transl Psychiatry       Date:  2015-03-17       Impact factor: 6.222

Review 9.  Olfaction in eating disorders and abnormal eating behavior: a systematic review.

Authors:  Mohammed A Islam; Ana B Fagundo; Jon Arcelus; Zaida Agüera; Susana Jiménez-Murcia; José M Fernández-Real; Francisco J Tinahones; Rafael de la Torre; Cristina Botella; Gema Frühbeck; Felipe F Casanueva; José M Menchón; Fernando Fernandez-Aranda
Journal:  Front Psychol       Date:  2015-09-30

10.  Parental age effects on odor sensitivity in healthy subjects and schizophrenia patients.

Authors:  Dolores Malaspina; Julie Walsh-Messinger; Daniel Antonius; Roberta Dracxler; Karen Rothman; Jennifer Puthota; Caitlin Gilman; Jessica L Feuerstein; David Keefe; Deborah Goetz; Raymond R Goetz; Peter Buckley; Douglas S Lehrer; Michele Pato; Carlos Pato
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-07-29       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.